Cantor Fitzgerald Maintains Mereo BioPharma(MREO.US) With Buy Rating, Maintains Target Price $7

Moomoo NewsMar 27 14:31 ET · Ratings

Mereo Wins New Overweight at J.P. Morgan Ahead of Trial Readouts

Seeking AlphaMar 27 11:38 ET

European Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading

MT NewswiresMar 27 11:21 ET

This Roper Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

BenzingaMar 27 08:52 ET

Cantor Fitzgerald Remains a Buy on Mereo Biopharma Group Plc (MREO)

TipRanksMar 27 08:25 ET · Ratings

LifeSci Capital Maintains Mereo BioPharma(MREO.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsMar 27 03:32 ET · Ratings